The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 6, 2016, Pages 806-818

  Feldman, Charles ^a,b   Anderson, Ronald ^c,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^c Institute for Cellular and Molecular Medicine   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

adjuvant therapy; antibiotics; biomarkers; burden of disease; cardiac events; community acquired pneumonia; mortality; pneumococcus; pneumolysin; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CRYOPYRIN; INFLAMMASOME; PNEUMOLYSIN;

ANTIBIOTIC THERAPY; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMPLEMENT ACTIVATION; DISEASE SEVERITY; EXTRACELLULAR TRAP; HEART DISEASE; HEART INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE ACTIVATION; COMMUNITY ACQUIRED INFECTION; COMPLICATION; MICROBIOLOGY;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, PNEUMOCOCCAL; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 85006062509     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1592074     Document Type: Article

References (161)

1. File T M Jr Marrie T J Burden of community-acquired pneumonia in North American adults Postgrad Med 2010 122 2 130 141
2. Isturiz R E Luna C M Ramirez J Clinical and economic burden of pneumonia among adults in Latin America Int J Infect Dis 2010 14 10 e852 e856
3. Shibl A M Memish Z A Ibrahim E Kanj S S Burden of adult community-acquired pneumonia in the Middle East/North Africa region Rev Med Microbiol 2010 21 1 11 20
4. Song J H Thamlikitkul V Hsueh P-R Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region Int J Antimicrob Agents 2011 38 2 108 117
5. Welte T Torres A Nathwani D Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 2012 67 1 71 79
6. Lozano R Naghavi M Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 2012 380 9859 2095 2128
7. Nunes M C von Gottberg A de Gouveia L, et al. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program PLoS ONE 2011 6 11 e27929
8. Chavanet P Pneumococcus infections: is the burden still as heavy? Med Mal Infect 2012 42 4 149 153
9. Blasi F Mantero M Santus P Tarsia P Understanding the burden of pneumococcal disease in adults Clin Microbiol Infect 2012 18 05 7 14
10. Ludwig E Bonanni P Rohde G Sayiner A Torres A The remaining challenges of pneumococcal disease in adults Eur Respir Rev 2012 21 123 57 65
11. Drijkoningen J J Rohde G G Pneumococcal infection in adults: burden of disease Clin Microbiol Infect 2014 20 05 45 51
12. Said M A Johnson H L Nonyane B A, et al; AGEDD Adult Pneumococcal Burden Study Team. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques PLoS ONE 2013 8 4 e60273
13. Sanz Herrero F Blanquer Olivas J Microbiology and risk factors for community-acquired pneumonia Semin Respir Crit Care Med 2012 33 3 220 231
14. Feldman C Anderson R Antibiotic resistance of pathogens causing community-acquired pneumonia Semin Respir Crit Care Med 2012 33 3 232 243
15. Cilloniz C Albert R K Liapikou A, et al. The effect of macrolide resistance on the presentation and outcome of patients hospitalized for Streptococcus pneumoniae pneumonia Am J Respir Crit Care Med 2015 191 11 1265 1272
16. Cillóniz C Ardanuy C Vila J Torres A What is the clinical relevance of drug-resistant pneumococcus? Curr Opin Pulm Med 2016 22 3 227 234
17. Torres A Peetermans W E Viegi G Blasi F Risk factors for community-acquired pneumonia in adults in Europe: a literature review Thorax 2013 68 11 1057 1065
18. Nuorti J P Butler J C Farley M M, et al; Active Bacterial Core Surveillance Team. Cigarette smoking and invasive pneumococcal disease N Engl J Med 2000 342 10 681 689
19. Kyaw M H Rose C E Jr Fry A M, et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults J Infect Dis 2005 192 3 377 386
20. Lynch J P III Zhanel G G Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines Curr Opin Pulm Med 2010 16 3 217 225
21. Chidiac C Pneumococcal infections and adult with risk factors Med Mal Infect 2012 42 10 517 524
22. van Hoek A J Andrews N Waight P A, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England J Infect 2012 65 1 17 24
23. Obert J Burgel P-R Pneumococcal infections: association with asthma and COPD Med Mal Infect 2012 42 5 188 192
24. Boikos C Quach C Risk of invasive pneumococcal disease in children and adults with asthma: a systematic review Vaccine 2013 31 42 4820 4826
25. Aspa J Rajas O Invasive pneumococcal disease and pneumococcal pneumonia: A review of the pertinent clinical issues Clin Pulm Med 2014 21 2 76 80
26. Bello S Menéndez R Torres A, et al. Tobacco smoking increases the risk for death from pneumococcal pneumonia Chest 2014 146 4 1029 1037
27. Torres A Blasi F Dartois N Akova M Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease Thorax 2015 70 10 984 989
28. Gili-Miner M López-Méndez J Béjar-Prado L Ramírez-Ramírez G Vilches-Arenas Á Sala-Turrens J Alcohol use disorders and community-acquired pneumococcal pneumonia: associated mortality, prolonged hospital stay and increased hospital spending Arch Bronconeumol 2015 51 11 564 570
29. Feldman C Anderson R Bacterial respiratory infections complicating human immunodeficiency virus Semin Respir Crit Care Med 2016 37 2 214 229
30. Brundage J F Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness Lancet Infect Dis 2006 6 5 303 312
31. van der Sluijs K F van der Poll T Lutter R Juffermans N P Schultz M J Bench-to-bedside review: bacterial pneumonia with influenza-pathogenesis and clinical implications Crit Care 2010 14 2 219
32. McCullers J A The co-pathogenesis of influenza viruses with bacteria in the lung Nat Rev Microbiol 2014 12 4 252 262
33. Robinson K M Kolls J K Alcorn J F The immunology of influenza virus-associated bacterial pneumonia Curr Opin Immunol 2015 34 59 67
34. McCullers J A Rehg J E Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor J Infect Dis 2002 186 3 341 350
35. Madhi S A Klugman K P; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia Nat Med 2004 10 8 811 813
36. McCullers J A Insights into the interaction between influenza virus and pneumococcus Clin Microbiol Rev 2006 19 3 571 582
37. Klugman K P Chien Y W Madhi S A Pneumococcal pneumonia and influenza: a deadly combination Vaccine 2009 27 03 C9 C14
38. Kuster S P Tuite A R Kwong J C McGeer A Fisman D N; Toronto Invasive Bacterial Diseases Network Investigators. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance PLoS Med 2011 8 6 e1001042
39. Alicino C Iudici R Alberti M Durando P The dangerous synergism between influenza and Streptococcus pneumoniae and innovative perspectives of vaccine prevention J Prev Med Hyg 2011 52 3 102 106
40. Davis B M Aiello A E Dawid S Rohani P Shrestha S Foxman B Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns Am J Epidemiol 2012 175 5 363 367
41. Vernatter J Pirofski L-A Current concepts in host-microbe interaction leading to pneumococcal pneumonia Curr Opin Infect Dis 2013 26 3 277 283
42. Wolter N Cohen C Tempia S, et al. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011 J Infect Dis 2014 209 1 56 65
43. Christenson B Hedlund J Lundbergh P Örtqvist A Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Eur Respir J 2004 23 3 363 368
44. Blay A Bessler H Lahad A Waitman D A Djaldetti M Does pneumococcal vaccine reduce influenza morbidity in humans? Vaccine 2007 25 6 1071 1075
45. Chien Y W Klugman K P Morens D M Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic J Infect Dis 2010 202 11 1639 1648
46. Crowe S Utley M Walker G Grove P Pagel C A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza Vaccine 2011 29 31 5065 5077
47. Chien Y-W Levin B R Klugman K P The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions PLoS ONE 2012 7 1 e29219
48. Gilchrist S A Nanni A Levine O Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers Am J Public Health 2012 102 4 596 605
49. Chang Y C Chou Y J Liu J Y Yeh T F Huang N Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan - a representative population-based comparative study J Infect 2012 65 3 231 238
50. McGarry L J Gilmore K E Rubin J L Klugman K P Strutton D R Weinstein M C Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States BMC Infect Dis 2013 13 229
51. Domínguez A Castilla J Godoy P, et al; CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain. Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study Pediatr Infect Dis J 2013 32 4 330 334
52. Klugman K P Madhi S A Pneumococcal vaccines and flu preparedness Science 2007 316 5821 49 50
53. Corrales-Medina V F Musher D M Shachkina S Chirinos J A Acute pneumonia and the cardiovascular system Lancet 2013 381 9865 496 505
54. Krüger S Frechen D Cardiovascular complications and comorbidities in CAP. In: Chalmers JD, Pletz MW, Aliberti S, eds. Community-Acquired Pneumonia. Norwich, UK: European Respiratory Society Publications Eur Respir Monogr 2014 63 256 265
55. Feldman C Anderson R Community-acquired pneumonia: Pathogenesis of acute cardiac events and potential adjunctive therapies Chest 2015 148 2 523 532
56. Brown A O Millett E RC Quint J K Orihuela C J Cardiotoxicity during invasive pneumococcal disease Am J Respir Crit Care Med 2015 191 7 739 745
57. Arnold F W Ramirez J A The burden of cardiac complications in patients with community-acquired pneumonia J Clin Outcomes Manag 2016 23 4 173 180
58. Musher D M Rueda A M Kaka A S Mapara S M The association between pneumococcal pneumonia and acute cardiac events Clin Infect Dis 2007 45 2 158 165
59. Eurich D T Johnstone J J Minhas-Sandhu J K Marrie T J Majumdar S R Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study Heart 2012 98 14 1072 1077
60. Prina E Ranzani O T Torres A Community-acquired pneumonia Lancet 2015 386 9998 1097 1108
61. Mueller C Laule-Kilian K Scholer A Perruchoud A P B-type natriuretic peptide for risk stratification in community-acquired pneumonia J Intern Med 2005 258 4 391 393
62. Christ-Crain M Breidthardt T Stolz D, et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia J Intern Med 2008 264 2 166 176
63. Jeong K Y Kim K Kim T Y, et al. Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia Emerg Med J 2011 28 2 122 127
64. Krüger S Ewig S Kunde J Hartmann O Suttorp N Welte T; CAPNETZ Study Group. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ Thorax 2010 65 3 208 214
65. Nowak A Breidthardt T Christ-Crain M, et al. Direct comparison of three natriuretic peptides for prediction of short-and long-term mortality in patients with community-acquired pneumonia Chest 2012 141 4 974 982
66. Kolditz M Ewig S Höffken G Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Eur Respir J 2013 41 4 974 984
67. Florin T A Ambroggio L Biomarkers for community-acquired pneumonia in the emergency department Curr Infect Dis Rep 2014 16 12 451
68. Chang C L Mills G D Karalus N C, et al. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults PLoS ONE 2013 8 5 e62612
69. Viasus D Del Rio-Pertuz G Simonetti A F, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis J Infect 2016 72 3 273 282
70. Mitchell T J Dalziel C E The biology of pneumolysin In: Anderluh G Gilbert R, eds. MACPF/CDC Proteins - Agents of Defence, Attack and Invasion Dordrecht Springer 2014 145 160
71. Price K E Camilli A Pneumolysin localizes to the cell wall of Streptococcus pneumoniae J Bacteriol 2009 191 7 2163 2168
72. Feldman C Mitchell T J Andrew P W, et al. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro Microb Pathog 1990 9 4 275 284
73. Feldman C Munro N C Jeffery P K, et al. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo Am J Respir Cell Mol Biol 1991 5 5 416 423
74. Canvin J R Marvin A P Sivakumaran M, et al. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus J Infect Dis 1995 172 1 119 123
75. Kadioglu A Gingles N A Grattan K Kerr A Mitchell T J Andrew P W Host cellular immune response to pneumococcal lung infection in mice Infect Immun 2000 68 2 492 501
76. Witzenrath M Gutbier B Hocke A C, et al. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia Crit Care Med 2006 34 7 1947 1954
77. García-Suárez MdelM Flórez N Astudillo A, et al. The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model Respir Res 2007 8 3
78. Karlström A Boyd K L English B K McCullers J A Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza J Infect Dis 2009 199 3 311 319
79. Hotomi M Yuasa J Briles D E Yamanaka N Pneumolysin plays a key role at the initial step of establishing pneumococcal nasal colonization Folia Microbiol (Praha) 2016 61 5 375 383
80. Aberdein J D Cole J Bewley M A Marriott H M Dockrell D H Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing Clin Exp Immunol 2013 174 2 193 202
81. Bewley M A Naughton M Preston J, et al. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation MBio 2014 5 5 e01710 e01714
82. González-Juarbe N Gilley R P Hinojosa C A, et al. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia PLoS Pathog 2015 11 12 e1005337
83. Littmann M Albiger B Frentzen A Normark S Henriques-Normark B Plant L Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression EMBO Mol Med 2009 1 4 211 222
84. Colino J Snapper C M Two distinct mechanisms for induction of dendritic cell apoptosis in response to intact Streptococcus pneumoniae J Immunol 2003 171 5 2354 2365
85. Davies L C Jenkins S J Allen J E Taylor P R Tissue-resident macrophages Nat Immunol 2013 14 10 986 995
86. Aggarwal N R King L S D'Alessio F R Diverse macrophage populations mediate acute lung inflammation and resolution Am J Physiol Lung Cell Mol Physiol 2014 306 8 L709 L725
87. Tarassishin L Suh H S Lee S C Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway J Neuroinflammation 2011 8 187
88. Günthner R Anders H J Interferon-regulatory factors determine macrophage phenotype polarization Mediators Inflamm 2013 2013 731023
89. Pelegrin P Surprenant A Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates EMBO J 2009 28 14 2114 2127
90. Liu W Zhang X Zhao M, et al. Activation in M1 but not M2 macrophages contributes to cardiac remodeling after myocardial infarction in rats: a critical role of the calcium sensing receptor/NRLP3 inflammasome Cell Physiol Biochem 2015 35 6 2483 2500
91. Hwang I Yang J Hong S, et al. Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4 Immunol Cell Biol 2015 93 6 591 599
92. Witzenrath M Pache F Lorenz D, et al. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia J Immunol 2011 187 1 434 440
93. McNeela E A Burke A Neill D R, et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4 PLoS Pathog 2010 6 11 e1001191
94. Harvey R M Hughes C E Paton A W Trappetti C Tweten R K Paton J C The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent PLoS ONE 2014 9 8 e103625
95. Lemon J K Miller M R Weiser J N Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance Infect Immun 2015 83 8 3204 3212
96. Karmakar M Katsnelson M Malak H A, et al. Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux J Immunol 2015 194 4 1763 1775
97. Kim J Y Paton J C Briles D E Rhee D K Pyo S Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia Oncotarget 2015 6 42 44161 44178
98. Lemon J K Weiser J N Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin MBio 2015 6 1 e02110 e02114
99. Di Paolo N C Doronin K Baldwin L K Papayannopoulou T Shayakhmetov D M The transcription factor IRF3 triggers "defensive suicide" necrosis in response to viral and bacterial pathogens Cell Reports 2013 3 6 1840 1846
100. Ali Y M Kenawy H I Muhammad A Sim R B Andrew P W Schwaeble W J Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae PLoS ONE 2013 8 12 e82583
101. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter Immunity 2013 38 6 1142 1153
102. Shoma S Tsuchiya K Kawamura I, et al. Critical involvement of pneumolysin in production of interleukin-1α and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation Infect Immun 2008 76 4 1547 1557
103. Grailer J J Canning B A Kalbitz M, et al. Critical role for the NLRP3 inflammasome during acute lung injury J Immunol 2014 192 12 5974 5983
104. Brinkmann V Reichard U Goosmann C, et al. Neutrophil extracellular traps kill bacteria Science 2004 303 5663 1532 1535
105. Nel J G Theron A J Pool R, et al. Neutrophil extracellular traps and their role in health and disease S Afr J Sci 2016 112 1/2 :Art# 2015-0072
106. G. Nel J Theron A J Durandt C, et al. Pneumolysin activates neutrophil extracellular trap formation Clin Exp Immunol 2016 184 3 358 367
107. Wartha F Beiter K Albiger B, et al. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps Cell Microbiol 2007 9 5 1162 1171
108. Beiter K Wartha F Albiger B Normark S Zychlinsky A Henriques-Normark B An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps Curr Biol 2006 16 4 401 407
109. Saffarzadeh M Juenemann C Queisser M A, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones PLoS ONE 2012 7 2 e32366
110. Ward P A Grailer J J Acute lung injury and the role of histones Transl Respir Med 2014 2 1
111. Sreeramkumar V Adrover J M Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation Science 2014 346 6214 1234 1238
112. Witzenrath M Gutbier B Owen J S, et al. Role of platelet-activating factor in pneumolysin-induced acute lung injury Crit Care Med 2007 35 7 1756 1762
113. Howard K M Differential expression of platelet-activating factor acetylhydrolase in lung macrophages Am J Physiol Lung Cell Mol Physiol 2009 297 6 L1141 L1150
114. Spreer A Kerstan H Böttcher T, et al. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone Antimicrob Agents Chemother 2003 47 8 2649 2654
115. Wall E C Gordon S B Hussain S, et al. Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality Clin Infect Dis 2012 54 5 701 705
116. Anderson R Nel J G Theron A J, et al. Pneumolysin triggers the production of platelet-activating factor by human neutrophils in vitro. Thorax 2015 70 03 A49
117. Ohkuni H Nagamune H Ozaki N, et al. Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor APMIS 2012 120 1 56 71
118. Varga-Szabo D Braun A Nieswandt B Calcium signaling in platelets J Thromb Haemost 2009 7 7 1057 1066
119. Nel J G Durandt C Mitchell T J Feldman C Anderson R Tintinger G R Pneumolysin mediates platelet activation in vitro Lung 2016 194 4 589 593
120. Etulain J Martinod K Wong S L Cifuni S M Schattner M Wagner D D P-selectin promotes neutrophil extracellular trap formation in mice Blood 2015 126 2 242 246
121. Caudrillier A Kessenbrock K Gilliss B M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury J Clin Invest 2012 122 7 2661 2671
122. Feldman C Anderson R Prevalence, pathogenesis, therapy and prevention of cardiovascular events in patients with community-acquired pneumonia Pneumonia 2016 8 11
123. Brown A O Mann B Gao G, et al. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function PLoS Pathog 2014 10 9 e1004383
124. Alhamdi Y Neill D R Abrams S T, et al. Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection PLoS Pathog 2015 11 5 e1004836
125. Alhamdi Y Abrams S T Cheng Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis Crit Care Med 2015 43 10 2094 2103
126. Alhamdi Y Zi M Abrams S T, et al. Circulating histone concentrations differentially affect the predominance of left or right ventricular dysfunction in critical illness Crit Care Med 2016 44 5 e278 e288
127. Borissoff J I ten Cate H From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism? J Thromb Haemost 2011 9 9 1791 1794
128. Mangold A Alias S Scherz T, et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size Circ Res 2015 116 7 1182 1192
129. Stakos D A Kambas K Konstantinidis T, et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction Eur Heart J 2015 36 22 1405 1414
130. Lam F Cruz M Parikh K Rumbaut R Histones stimulate ultra-large von Willebrand factor release from endothelium: a potential contributor to the prothrombotic state in sepsis FASEB J 2015 29 1 :supplement 631.13
131. Merten M Thiagarajan P P-selectin in arterial thrombosis Z Kardiol 2004 93 11 855 863
132. Woodhead M Noor M Empirical antibiotic management of adult CAP. In: Chalmers JD, Pletz MW, Aliberti S, eds. Community-Acquired Pneumonia. Norwich, UK: European Respiratory Society Publications Eur Respir Monogr 2014 63 140 154
133. Mandell L A Wunderink R G Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 2007 44 02 S27 S72
134. Woodhead M Blasi F Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections - full version Clin Microbiol Infect 2011 17 06 E1 E59
135. Waterer G W Somes G W Wunderink R G Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia Arch Intern Med 2001 161 15 1837 1842
136. Baddour L M Yu V L Klugman K P, et al; International Pneumococcal Study Group. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia Am J Respir Crit Care Med 2004 170 4 440 444
137. Gattarello S Borgatta B Solé-Violán J, et al; Community-Acquired Pneumonia en la Unidad de Cuidados Intensivos II Study Investigators*. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013) Chest 2014 146 1 22 31
138. Gattarello S What is new in antibiotic therapy in community-acquired pneumonia? An evidence-based approach focusing on combined therapy Curr Infect Dis Rep 2015 17 10 501
139. Emmet O'Brien M Restrepo M I Martin-Loeches I Update on the combination effect of macrolide antibiotics in community-acquired pneumonia Respir Investig 2015 53 5 201 209
140. García-Suárez MdelM Cima-Cabal M D Flórez N, et al. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin Infect Immun 2004 72 8 4534 4540
141. Henry B D Neill D R Becker K A, et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice Nat Biotechnol 2015 33 1 81 88
142. Li H Zhao X Wang J, et al. β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection Sci Rep 2015 5 17668
143. Zhao X Li H Wang J, et al. Verbascoside alleviates pneumococcal pneumonia by reducing pneumolysin oligomers Mol Pharmacol 2016 89 3 376 387
144. Fukuda Y Yanagihara K Higashiyama Y, et al. Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Eur Respir J 2006 27 5 1020 1025
145. Anderson R Steel H C Cockeran R, et al. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro J Antimicrob Chemother 2007 60 5 1155 1158
146. Anderson R Steel H C Cockeran R, et al. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae J Antimicrob Chemother 2007 59 2 224 229
147. Cockeran R Steel H C Wolter N, et al. Effects of clarithromycin at sub-minimum inhibitory concentrations on early ermB gene expression, metabolic activity and growth of an erm (B)-expressing macrolide-resistant strain of Streptococcus pneumoniae. Open J Respir Dis 2012 2 1 :Paper ID 17694
148. Hirst R A Mohammed B J Mitchell T J Andrew P W O'Callaghan C Streptococcus pneumoniae-induced inhibition of rat ependymal cilia is attenuated by antipneumolysin antibody Infect Immun 2004 72 11 6694 6698
149. Rae N Finch S Chalmers J D Cardiovascular disease as a complication of community-acquired pneumonia Curr Opin Pulm Med 2016 22 3 212 218
150. Trac M H McArthur E Jandoc R, et al. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults CMAJ 2016 188 7 E120 E129
151. Statt S Ruan J W Hung L Y, et al. Statin-conferred enhanced cellular resistance against bacterial pore-forming toxins in airway epithelial cells Am J Respir Cell Mol Biol 2015 53 5 689 702
152. Rosch J W Boyd A R Hinojosa E, et al. Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease J Clin Invest 2010 120 2 627 635
153. Havers F Bramley A M Finelli L, et al. Statin use and hospital length of stay among adults hospitalized with community-acquired pneumonia Clin Infect Dis 2016 62 12 1471 1478
154. Steel H C Theron A J Cockeran R Anderson R Feldman C Pathogen-and host-directed anti-inflammatory activities of macrolide antibiotics Mediators Inflamm 2012 2012 584262
155. Siemieniuk R A Meade M O Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis Ann Intern Med 2015 163 7 519 528
156. Feldman C Anderson R Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials J Thorac Dis 2016 8 3 E162 E171
157. Berjohn C M Fishman N O Joffe M M Edelstein P H Metlay J P Treatment and outcomes for patients with bacteremic pneumococcal pneumonia Medicine (Baltimore) 2008 87 3 160 166
158. Mongardon N Max A Bouglé A, et al. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study Crit Care 2012 16 4 R155
159. Weinberger D M Harboe Z B Sanders E A, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis Clin Infect Dis 2010 51 6 692 699
160. Luján M Gallego M Belmonte Y, et al. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Eur Respir J 2010 36 5 1073 1079
161. Mortensen E M Metersky M L Long-term mortality after pneumonia Semin Respir Crit Care Med 2012 33 3 319 324